Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma
Authors:
- 1 October 2019
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 105 (2) , 307-318
Abstract
No abstract availableKeywords
Funding Information
- Tri-Service General Hospital
- Chi Mei Medical Center
This publication has 34 references indexed in Scilit:
- Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular CarcinomaPLOS ONE, 2013
- Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2012
- Stereotactic Body Radiation Therapy in Recurrent Hepatocellular CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver functionEuropean Journal of Radiology, 2012
- Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteriaLiver Transplantation, 2011
- Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinomaJournal of Surgical Oncology, 2010
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Surgical treatment of hepatocellular carcinomaHPB, 2005
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002